These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31075871)

  • 1. Effects of Combined Remote Ischemic Pre-and Post-Conditioning on Neurologic Complications in Moyamoya Disease Patients Undergoing Superficial Temporal Artery-Middle Cerebral Artery Anastomosis.
    Choi ES; Lee YS; Park BS; Kim BG; Sohn HM; Jeon YT
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31075871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial.
    Hong DM; Lee EH; Kim HJ; Min JJ; Chin JH; Choi DK; Bahk JH; Sim JY; Choi IC; Jeon Y
    Eur Heart J; 2014 Jan; 35(3):176-83. PubMed ID: 24014392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: a single-center, double-blind, randomized controlled trial.
    Wang G; Zhang Y; Yang L; Chen Y; Fang Z; Zhou H; Zhang C; Lei G; Shi S; Li J
    BMC Anesthesiol; 2019 Apr; 19(1):48. PubMed ID: 30954071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery--randomized controlled trial.
    Hong DM; Jeon Y; Lee CS; Kim HJ; Lee JM; Bahk JH; Kim KB; Hwang HY
    Circ J; 2012; 76(4):884-90. PubMed ID: 22301846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Protective Effects of Remote Ischaemic Preconditioning with Postconditioning in Patients Undergoing Cardiac Surgery Involving Cardiopulmonary Bypass: A Substudy of the Remote Ischaemic Preconditioning with Postconditioning Outcome trial.
    Min JJ; Bae JY; Kim TK; Kim JH; Hwang HY; Kim KH; Ahn H; Oh AY; Bahk JH; Hong DM; Jeon Y
    Heart Lung Circ; 2016 May; 25(5):484-92. PubMed ID: 26585832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease].
    Fujimura M; Mugikura S; Shimizu H; Tominaga T
    No Shinkei Geka; 2006 Aug; 34(8):801-9. PubMed ID: 16910493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote ischemic postconditioning protects the brain from focal ischemia/reperfusion injury by inhibiting autophagy through the mTOR/p70S6K pathway.
    Chen GZ; Shan XY; Li XS; Tao HM
    Neurol Res; 2018 Mar; 40(3):182-188. PubMed ID: 29369005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of Remote Ischemic Preconditioning and Postconditioning Outcome (RISPO) trial in patients undergoing cardiac surgery.
    Cho YJ; Lee EH; Lee K; Kim TK; Hong DM; Chin JH; Choi DK; Bahk JH; Sim JY; Choi IC; Jeon Y
    Int J Cardiol; 2017 Mar; 231():84-89. PubMed ID: 28043669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Adventitial Dissection of Superficial Temporal Artery on the Outcome of Superficial Temporal Artery-Middle Cerebral Artery Bypass in Moyamoya Disease.
    Li X; Huang Z; Wu MX; Zhang D
    Aging Dis; 2017 Jul; 8(4):384-391. PubMed ID: 28840053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of moyamoya disease by superficial temporal artery-middle cerebral artery anastomosis].
    Li Z; Kong L; Han G; Li G; Feng S; Liu Y; Jin F
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(43):3501-4. PubMed ID: 26813272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of three remote ischemic conditioning procedures against renal ischemic/reperfusion injury in rat kidneys: a comparative study.
    Jiang H; Chen R; Xue S; Zhu H; Sun X; Sun X
    Ir J Med Sci; 2015 Sep; 184(3):647-53. PubMed ID: 25398631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Superficial Temporal Artery-to-Middle Cerebral Artery Anastomosis in Treating Moyamoya Disease by Reducing Endothelial Progenitor Cells.
    Zhang W; Wang X; Wang Z; Shang J; Wang H; Yin G
    World Neurosurg; 2016 Sep; 93():365-70. PubMed ID: 27350298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial temporal artery-middle cerebral artery anastomosis patency correlates with cerebrovascular reserve in adult moyamoya syndrome patients.
    Aboukais R; Verbraeken B; Leclerc X; Gautier C; Henon H; Vermandel M; Menovsky T; Lejeune JP
    Neurochirurgie; 2019 Aug; 65(4):146-151. PubMed ID: 31185229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
    Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.
    Hwang JW; Yang HM; Lee H; Lee HK; Jeon YT; Kim JE; Lim YJ; Park HP
    Br J Anaesth; 2013 May; 110(5):773-9. PubMed ID: 23274781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.